While dose adjustment is not generally required for mild to moderate renal or hepatic impairment, tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is not recommended in these populations
Read more Compare top GLP-1 apps for 2026
Whether Medicaid covers weight loss shots like Wegovy depends entirely on your state
Further studies are needed for elucidation
Specific situations that warrant immediate medical attention regardless of what the plotter shows include severe or persistent nausea and vomiting that does not improve within 48 hours, signs of pancreatitis (severe abdominal pain radiating to the back), allergic reactions (rash, difficulty breathing, swelling), significant changes in vision, and any symptom that feels medically emergent
Active Living Strategy: Your plan includes customized recommendations for physical activity, with an emphasis on resistance training